Identification of TAK-756, A Potent TAK1 Inhibitor for the Treatment of Osteoarthritis through Intra-Articular Administration
Year: 2024
Type: article
Source: Journal of Medicinal Chemistry
Authors: Jean-Baptiste Langlois, Silke Brenneisen, Stephane Rodde, Eric Vangrevelinghe, Geoffroy Rose, Patrick Lerch, Mickael Sorge, Thomas Ullrich, Krystyna Patora-Komisarska, Jean Quancard, Patrice Larger, Lucas Gianola, Claudia Textor, Gaelle Chenal, Tina Rubic-Schneider, Katerina Simkova, Olga Masmanidou, Clemens Scheufler, Alfred Lammens, Anais Bouzan, Sabrina Demirci, Ludivine Flotte, Helene Rivet, Lilian Hartmann, Danyel Guezel, Manuela Flueckiger, Alain Schilb, Edi Schuepbach, Rachel Kettle, Carsten Jacobi, David Pearson, Peter J. Richards, Giulia C. Minetti
Institution: Novartis (Switzerland)
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404626927